Business Context and Reporting Period
Company: Alterity Therapeutics Limited
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of May 2020
Date Filed: May 25, 2020
Principal Executive Office: Level 3, 460 Bourke Street, Melbourne, VIC 3000, Australia
Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a procedural notice rather than a financial report.
Material Changes
No material financial changes or operational updates are disclosed in this specific filing text.
Guidance, Outlook, and Risks
Item 99.1: The filing contains an Appendix 2A and Section 708A(5) Cleansing Notice.
Registration Statements: This Form 6-K is incorporated by reference into Registration Statement on Form S-8 (File No. 333-228671) and Registration Statements on Form F-3 (Files No. 333-220886 and 333-231417).
Management Commentary: None provided in this text.
Key Facts for Investor Verification
- Verify the specific content of the "Appendix 2A and Section 708A(5) Cleansing Notice" referenced in Item 99.1, as the text does not detail the notice's substance.
- Review the referenced Registration Statements (S-8 and F-3) for details on equity offerings or employee compensation plans.
- Confirm that no financial performance data is included in this specific 6-K filing.